Zilico Limited Revenue and Competitors

Manchester,

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Zilico Limited's estimated annual revenue is currently $4.5M per year.(i)
  • Zilico Limited's estimated revenue per employee is $251,000

Employee Data

  • Zilico Limited has 18 Employees.(i)
  • Zilico Limited grew their employee count by 6% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M40-18%$10MN/A
#2
$24.8M9929%N/AN/A
#3
$139.8M68516%$200KN/A
#4
$84.1M0N/A$1.2MN/A
#5
$35.6M14230%N/AN/A
#6
$54.5M21715%N/AN/A
#7
$52.7M16825%$129.6MN/A
#8
$21.8M87-13%N/AN/A
#9
$70M2799%N/AN/A
#10
$60.6M19320%$115.5MN/A
Add Company

Zilico Ltd is a UK based company which specialises in the design and manufacture of real-time medical diagnostics to address specific clinical needs. ZedScanâ„¢, Zilico's pioneering flagship product utilises Electrical Impedance Spectroscopy (EIS) to improve the ability to detect cervical intraepithelial neoplasia (CIN) following an abnormal smear result, increasing diagnostic accuracy and delivering health economic benefits. Zilico's patented EIS technology exploits the different electrical resistivity associated with the cellular structure of normal, pre-cancerous and cancerous tissue, which based on its applicability to other types of neoplasia, substantiates its use as a platform for the rapid, reliable and reproducible detection and diagnosis of disease.

keywords:N/A

N/A

Total Funding

18

Number of Employees

$4.5M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Zilico Limited News

2022-04-06 - Cervical Cancer Diagnostic Tests Market Focus On ...

Zilico Ltd. Guided Therapeutics Inc. OncoHealth Corp. Cervical Cancer Diagnostic Tests Market Segmentation: The report surveys the presence of...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.6M18N/AN/A
#2
N/A1864%N/A
#3
$1.6M180%N/A
#4
$3.6M18-59%N/A
#5
$2.3M1927%N/A